Nijhawan Pardeep 4

What Happened

• Pardeep Nijhawan, CEO of Edesa Biotech, reported an open-market purchase of 1,000 shares of EDSA common stock on March 10, 2026.
• The purchase price was $6.60 per share for a total reported value of $6,599.
• This was a purchase (potentially a bullish signal compared with a sale), not a sale, option exercise, gift, or award.

Key Details

• Transaction date: 2026-03-10; Transaction code: P (purchase).
• Price per share: $6.60; Total value: $6,599.
• Shares owned after the transaction: not specified in the provided filing details.
• Footnotes: (F1) Several entities (Pardeep Medicine Professional Corporation, The Digestive Health Clinic Inc., and 1968160 Ontario Inc.) are wholly owned by the reporting person; he disclaims beneficial ownership except to the extent of his pecuniary interest. (F2) Reporting person is co-trustee of The New Nijhawan Family Trust 2015 and similarly disclaims beneficial ownership except to his pecuniary interest.
• Filing appears timely (report and transaction dated 2026-03-10).

Context

• This was an open-market purchase — a direct buy rather than an option exercise or award. Purchases by executives can be of interest to investors as they indicate the insider spent personal funds to acquire shares, but they do not by themselves prove future company performance.
• The disclaimers in the footnotes mean some shares may be held indirectly through related entities or trusts; the reporting person limits claimed beneficial ownership to his pecuniary interest.